Abstract 16113: CT Pulmonary Angiography Yield in Patients With an Active Malignancy: Lack of Non-invasive Screening
Patients with an active malignancy are at increased risk of venous thromboembolism due to the production of pro-coagulant factors causing a hypercoagulable state. Providers must keep their index of suspicion high for a pulmonary embolism in these patients because of the high prevalence and often vague symptoms. This is a retrospective study of 2226 patients who underwent CT pulmonary angiography (CTPA) in the emergency department. We compared the diagnosis of PE in patients with and without an active malignancy within the past 6 months. Of those patients without an active cancer, 133/1788 (7.4%) patients were diagnosed with a PE. This is not significantly different from the cohort with cancer where 37/437 (8.5%) patients were diagnosed with a PE (p=0.468). During diagnosis, patients with a history of cancer were less likely to have a chest x-ray, d-dimer or troponin performed prior to the CTPA scan (Table 1). These tests are less invasive and much cheaper than the CTPA and can help identify other pathologies that a patient may be experiencing. Not surprisingly, patients with a malignancy have a higher Wells’ score, revised Geneva score and PERC rule (Table 2), leading providers further down diagnostic algorithms towards CTPA. While many of these high-risk patients should immediately undergo CTPA, patients at low or moderate risk of PE should first be evaluated with less invasive testing such as a chest x-ray or d-dimer. In conclusion, in order to decrease the number of patients unnecessarily undergoing CTPA, patients with an active malignancy should be risk stratified in a similar manner as those patients without a malignancy, including the use of non-invasive testing where appropriate.